Testing effectiveness (Phase 2)Ended earlyNCT01552681
What this trial is testing
Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome
Who this might be right for
Primary Sjögren's Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 52